SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS
申请人:Chow Ken
公开号:US20080255239A1
公开(公告)日:2008-10-16
Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.
本文揭示了治疗化合物、方法、组合物和相关药物。
[EN] GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES<br/>[FR] CONJUGUÉS DE GALNAC ET D'UN INHIBITEUR DE TGFβR1 POUR LE TRAITEMENT DE MALADIES HÉPATIQUES
申请人:SILVERBACK THERAPEUTICS INC
公开号:WO2021072330A1
公开(公告)日:2021-04-15
Conjugates comprising GalNAc moiety and a TGFβR1 inhibitor are provided. In some embodiments, the conjugates are useful for the treatment of viral infections, cancer, and fibrosis.
ENOYL REDUCTASE INHIBITORS WITH ANTIBACTERIAL ACTIVITY
申请人:JOHNSON Michael
公开号:US20150246888A1
公开(公告)日:2015-09-03
Disclosed are compounds and compositions useful as antibacterials. In particular, disclosed are enoyl reductase (FabI) inhibitors, compositions comprising such compounds, processes for producing such compounds, and methods of using such compounds.